# US 2025/0166249 A1 · Parametric imaging without pre-scan blood input function

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0166249 A1
- Document ID: US20250166249A1
- Status: Published application
- Kind: A1
- Application number: 18/514,169
- Filed: 2023-11-20
- Published: 2025-05-22
- Earliest claimed: 2023-11-20
- Assignees: Siemens Medical Solutions USA, Inc.
- Applicants: Siemens Medical Solutions USA, Inc.
- Inventors: Vladimir Panin; David Pigg
- Web page: https://patentgrep.com/patent/US20250166249A1

## CPC

- G06T 12/30: Image post-processing, e.g. metal artefact correction
- A61B 6/037: {Emission tomography}
- A61B 6/486: {involving generating temporal series of image data}
- A61B 6/507: {for determination of haemodynamic parameters, e.g. perfusion CT}
- A61B 6/5205: {involving processing of raw data to produce diagnostic data}
- A61B 6/5217: {extracting a diagnostic or physiological parameter from medical diagnostic data}
- A61B 6/5235: {combining images from the same or different ionising radiation imaging techniques, e.g. PET and CT}
- G06T 7/0016: {involving temporal comparison}
- G06T 12/20: Inverse problem, i.e. transformations from projection space into object space
- G06T 2207/10104: Positron emission tomography [PET]
- G06T 2207/30101: Blood vessel; Artery; Vein; Vascular
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Systems and methods include acquisition of positron emission tomography (PET) data of a volume comprising blood and tissue, determination, from the acquired PET data, of a blood input function (BIF) from a time at which non-metabolized radionuclide tracer within the volume has reached a steady state between the blood and the tissue, and determination of parametric images based on the acquired PET data, the determined BIF and a parametric model which does not include BIF values prior to the time.

## Claims

### Claim 1

A positron emission tomography (PET) scanner system comprising:
an injector to inject a tracer into a volume comprising blood and tissue;
at least one processing unit to:
acquire PET data of the volume after non-metabolized tracer has reached a steady state between the blood and the tissue;
determine a blood input function (BIF) of the volume from the acquired PET data; and
determine parametric images based on the acquired PET data, the BIF and a parametric model comprising basis functions which do not include BIF values prior to the steady state, where each parametric image is associated with a respective one of the basis functions; and
a display to display the parametric images.

### Claim 2 (depends on 1)

The system of claim 1, wherein determination of the parametric images comprises:
reconstruction of a plurality of standardized uptake value (SUV) images based on the acquired PET data, each of the plurality of SUV images associated with a respective PET data acquisition time period;
extraction of a time-activity curve for each image voxel of the SUV images based on the SUV images; and
fitting of the parametric model to the time-activity curves.

### Claim 3 (depends on 2)

The system of claim 2, wherein determination of the BIF comprises:
acquisition of a computed tomography image of the volume;
determination of BIF voxels of interest based on the computed tomography image; and
determination of the BIF based on the voxels of interest of each of the SUV images.

### Claim 4 (depends on 1)

The system of claim 1, wherein determination of the parametric images comprises:
determination of the parametric images based on the parametric model and the acquired PET data within the reconstruction of a standardized uptake value (SUV) image.

### Claim 5 (depends on 4)

The system of claim 4, wherein determination of the BIF comprises:
acquisition of a computed tomography image of the volume;
determination of BIF voxels of interest based on the computed tomography image;
reconstruction of a plurality of standardized uptake value (SUV) images based on the acquired PET data, each of the plurality of SUV images associated with a respective PET data acquisition time period; and
determination of the BIF based on the voxels of interest of each of the SUV images.

### Claim 6 (depends on 1)

The system of claim 1, wherein the parametric model is:
C
t
(
t
)
-
C
t
(
t
*
)
=
K
i
⁢
∫
t
t
C
b
(
t
′
)
⁢
dt
′
+
DV
⁡
(
C
b
(
t
)
-
C
b
(
t
*
)
)
,
t
>
t
*
where t* is a time at which the non-metabolized tracer has reached a steady state between the blood and the tissue, Ct is the tracer activity concentration in tissue, Cb is the tracer concentration in arterial blood supplying the tissue, KI is the rate of irreversible uptake, and DV is the apparent distribution volume of the non-metabolized tracer.

### Claim 7 (depends on 1)

The system of claim 1, wherein the parametric model is:
C
t
(
t
)
=
α
⁢
C
b
(
t
)
-
α
⁢
e
t
-
t
*
β
⁢
C
b
(
t
*
)
-
α
⁢
∫
t
*
t
e
t
-
t
′
β
(
d
dt
′
⁢
C
b
(
t
′
)
)
⁢
dt
′
+
C
t
(
t
*
)
⁢
e
t
-
t
*
β
,
t
>
t
*
where t* is a time at which the non-metabolized tracer has reached a steady state between the blood and the tissue, Ct is the tracer activity concentration in tissue, and Cb is the tracer concentration in arterial blood supplying the tissue.

### Claim 8

A method comprising:
acquiring positron emission tomography (PET) data of a volume;
determining, from the acquired PET data, a blood input function (BIF) from a time at which non-metabolized radionuclide tracer within the volume has reached a steady state between blood and tissue of the volume; and
determining parametric images based on the acquired PET data, the determined BIF and a parametric model which does not include BIF values prior to the time.

### Claim 9 (depends on 8)

The method of claim 8, wherein determining the parametric images comprises:
reconstructing a plurality of standardized uptake value (SUV) images based on the acquired PET data, each of the plurality of SUV images associated with a respective PET data acquisition time period;
extracting a time-activity curve for each image voxel of the SUV images based on the SUV images; and
fitting the parametric model to the time-activity curves.

### Claim 10 (depends on 9)

The method of claim 9, wherein determining the BIF comprises:
acquiring a computed tomography image of the volume;
determining BIF voxels of interest based on the computed tomography image; and
determining the BIF based on the voxels of interest of each of the SUV images.

### Claim 11 (depends on 8)

The method of claim 8, wherein determining the parametric images comprises:
determining the parametric images based on the parametric model and the acquired PET data within the reconstruction of a standardized uptake value (SUV) image.

### Claim 12 (depends on 11)

The method of claim 11, wherein determining the BIF comprises:
acquiring a computed tomography image of the volume;
determining BIF voxels of interest based on the computed tomography image;
reconstructing a plurality of standardized uptake value (SUV) images based on the acquired PET data, each of the plurality of SUV images associated with a respective PET data acquisition time period; and
determining the BIF based on the voxels of interest of each of the SUV images.

### Claim 13 (depends on 8)

The method of claim 8, wherein the parametric model is:
C
t
(
t
)
-
C
t
(
t
*
)
=
K
i
⁢
∫
t
t
C
b
(
t
′
)
⁢
dt
′
+
DV
⁡
(
C
b
(
t
)
-
C
b
(
t
*
)
)
,
t
>
t
*
where t* is a time at which the non-metabolized tracer has reached a steady state between the blood and the tissue, Ct is the tracer activity concentration in tissue, Cb is the tracer concentration in arterial blood supplying the tissue, KI is the rate of irreversible uptake, and DV is the apparent distribution volume of the non-metabolized tracer.

### Claim 14 (depends on 8)

The method of claim 8, wherein the parametric model is:
C
t
(
t
)
=
α
⁢
C
b
(
t
)
-
α
⁢
e
t
-
t
*
β
⁢
C
b
(
t
*
)
-
α
⁢
∫
t
*
t
e
t
-
t
′
β
(
d
dt
′
⁢
C
b
(
t
′
)
)
⁢
dt
′
+
C
t
(
t
*
)
⁢
e
t
-
t
*
β
,
t
>
t
*
where t* is a time at which the non-metabolized tracer has reached a steady state between the blood and the tissue, Ct is the tracer activity concentration in tissue, and Cb is the tracer concentration in arterial blood supplying the tissue.

### Claim 15

A non-transitory medium storing program code, the program code executable by at least one processing unit to cause a computing system to:
acquire positron emission tomography (PET) data of a volume comprising blood and tissue;
determine, from the acquired PET data, a blood input function (BIF) from a time at which non-metabolized radionuclide tracer within the volume has reached a steady state between the blood and the tissue; and
determine parametric images based on the acquired PET data, the determined BIF and a parametric model which does not include BIF values prior to the time.

### Claim 16 (depends on 15)

The medium of claim 15, wherein determination of the parametric images comprises:
reconstruction of a plurality of standardized uptake value (SUV) images based on the acquired PET data, each of the plurality of SUV images associated with a respective PET data acquisition time period;
extraction of a time-activity curve for each image voxel of the SUV images based on the SUV images; and
fitting of the parametric model to the time-activity curves.

### Claim 17 (depends on 16)

The medium of claim 16, wherein determination of the BIF comprises:
acquisition of a computed tomography image of the volume;
determination of BIF voxels of interest based on the computed tomography image; and
determination of the BIF based on the voxels of interest of each of the SUV images.

### Claim 18 (depends on 15)

The medium of claim 15, wherein determination of the parametric images comprises:
determination of the parametric images based on the parametric model and the acquired PET data within the reconstruction of a standardized uptake value (SUV) image.

### Claim 19 (depends on 15)

The medium of claim 15, wherein the parametric model is:
C
t
(
t
)
-
C
t
(
t
*
)
=
K
i
⁢
∫
t
t
C
b
(
t
′
)
⁢
dt
′
+
DV
⁡
(
C
b
(
t
)
-
C
b
(
t
*
)
)
,
t
>
t
*
where t* is a time at which the non-metabolized tracer has reached a steady state between the blood and the tissue, Ct is the tracer activity concentration in tissue, Cb is the tracer concentration in arterial blood supplying the tissue, KI is the rate of irreversible uptake, and DV is the apparent distribution volume of the non-metabolized tracer.

### Claim 20 (depends on 15)

The medium of claim 15, wherein the parametric model is:
C
t
(
t
)
=
α
⁢
C
b
(
t
)
-
α
⁢
e
t
-
t
*
β
⁢
C
b
(
t
*
)
-
α
⁢
∫
t
*
t
e
t
-
t
′
β
(
d
dt
′
⁢
C
b
(
t
′
)
)
⁢
dt
′
+
C
t
(
t
*
)
⁢
e
t
-
t
*
β
,
t
>
t
*
where t* is a time at which the non-metabolized tracer has reached a steady state between the blood and the tissue, Ct is the tracer activity concentration in tissue, and Cb is the tracer concentration in arterial blood supplying the tissue.
